NatureWise Biotech & Medicals Corporation (TPEX:4732)
Taiwan · Delayed Price · Currency is TWD 19.00
-0.05 (-0.26%)
May 29, 2026, 1:11 PM CST
TPEX:4732 Revenue
In the year 2025, NatureWise Biotech & Medicals had annual revenue of 176.77M TWD, down -21.20%. NatureWise Biotech & Medicals had revenue of 86.77M in the half year ending June 30, 2025, with 30.75% growth.
Revenue
176.77M
Revenue Growth
-21.20%
P/S Ratio
5.07
Revenue / Employee
5.52M
Employees
31
Market Cap
895.40M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 176.77M | -47.56M | -21.20% |
| Dec 31, 2024 | 224.32M | 64.18M | 40.08% |
| Dec 31, 2023 | 160.14M | -68.45M | -29.94% |
| Dec 31, 2022 | 228.59M | -21.21M | -8.49% |
| Dec 31, 2021 | 249.80M | -57.12M | -18.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Level Biotechnology | 718.58M |
| Taiwan Advance Bio-Pharmaceutical | 364.79M |
| TCI GENE | 273.61M |
| BioLASCO Taiwan | 263.81M |
| GeneReach Biotechnology | 232.55M |
| Lukas Biomedical | 179.49M |
| Holy Stone Healthcare | 47.51M |
| Neith | 32.03M |